FCM
IDYA icon

Farallon Capital Management’s IDEAYA Biosciences IDYA Stock Holding History

Farallon Capital Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,000
Closed -$219K – 178
2024
Q1 		$219K Buy
+5,000
New +$215K ﹤0.01% 146

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Farallon Capital Management's IDYA Position: Q2 2024 in Review

Farallon Capital Management sold out of IDEAYA Biosciences (IDYA) in Q2 2024, closing a stake of 5,000 shares — an estimated $219K sold.

Farallon Capital Management first reported a position in IDYA in Q1 2024 and held it in 1 quarter. The position peaked at $219K in Q1 2024. 199 funds tracked by Wall St. Rank hold IDYA as of Q2 2024.

  • Farallon Capital Management reported no remaining IDEAYA Biosciences position as of Q2 2024 after selling out during the quarter.
  • Farallon Capital Management sold 5,000 IDEAYA Biosciences shares in Q2 2024, an estimated $219K.
  • Farallon Capital Management first reported a position in IDEAYA Biosciences in Q1 2024 and held it in 1 quarter.
  • Farallon Capital Management's IDEAYA Biosciences position peaked at $219K in Q1 2024.
  • 199 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2024.

Based on Farallon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.